FIELD: biotechnology.
SUBSTANCE: invention refers to biotechnology and represents a method for quantitative determination of antibodies that bind to AAV, in vitro, involving: (a) obtaining infectious recombinant AAV particles containing a recombinant AAV vector, wherein the recombinant AAV vector comprises a reporter transgene, wherein the reporter transgene comprises (a) a single-stranded or self-complementary genome, (b) is operably linked to one or more regulatory expression elements, and (c) is flanked by one or more flanking elements; (b) obtaining a biological sample from an individual; (c) obtaining cells that can be infected with said infectious particles of recombinant AAV; (d) bringing into contact or incubation of infectious particles of recombinant AAV (a) with biological sample (b), thereby obtaining the obtained mixture (M); (e) bringing the cells into contact (c) with the obtained mixture (M) under conditions in which the recombinant AAV (a) infectious particles can infect and express the reporter transgene in said cells; (f) measuring reporter transgene expression and (g) comparing said reporter transgene (f) expression with a negative (-) control reporter transgene, (i) an antibody-free transporter that binds to AAV, and (+) control, (ii) containing a predefined number of antibodies that bind to AAV, thereby quantitatively determining antibodies in the biological sample that bind to AAV.
EFFECT: disclosed are the AAV vector and neutralizing anti-AAV analysis.
64 cl, 5 tbl, 5 ex
Title |
Year |
Author |
Number |
VARIANT AAV, COMPOSITIONS AND METHODS, IN WHICH IT IS USED, AS WELL AS METHODS OF ITS APPLICATION FOR TRANSFER OF GENES INTO CELLS, ORGANS AND TISSUES |
2014 |
- Khaj Ketrin A.
- Yazisioglu Mustafa N.
- Angela Khaver
|
RU2697444C2 |
AAV VECTOR COMPOSITIONS AND METHODS FOR GENE TRANSFER TO CELLS, ORGANS AND TISSUES |
2013 |
- Khaj Katerine A.
- Mingozzi Federiko
- Sun Yunvej
- Dzhonson Filip
|
RU2653444C2 |
VERSION OF AAV, COMPOSITIONS AND METHODS IN WHICH IT IS USED, AS WELL AS METHODS OF USING IT FOR TRANSFERRING GENES INTO CELLS, ORGANS AND TISSUES |
2014 |
- High, Katherine A.
- Yazicioglu, Mustafa N.
- Anguela, Xavier
|
RU2837753C2 |
METHODS FOR AAV DETECTION |
2017 |
- Jin, Xiaoying
- O'Riordan, Catherine, R.
- Liu, Lin
- Zhang, Kate
|
RU2771622C2 |
RNAi AGENT OPTION |
2018 |
- O'Riordan, Catherine R.
- Palermo, Adam
- Richards, Brenda
- Stanek, Lisa M.
|
RU2789647C2 |
OBTAINING IMPROVED HUMAN PAH FOR TREATING SEVERE PKU WITH LIVER-TARGETED GENE REPLACEMENT THERAPY |
2019 |
- Kyostio-Moore, Sirkka
- Manavalan, Partha
|
RU2839587C2 |
SCALABLE METHODS FOR OBTAINING RECOMBINANT VECTOR BASED ON ADENO-ASSOCIATED VIRUS (AAV) IN SYSTEM OF SERUM-FREE SUSPENSION CELL CULTURE, SUITABLE FOR CLINICAL USE |
2016 |
- Qu, Guang
- Lu, Lin
- Wright, John Fraser
|
RU2766583C2 |
ADENO-ASSOCIATED VIRAL VECTORS FOR TREATMENT OF MYOCILIN (MYOC) GLAUCOMA |
2015 |
- Pechan, Peter
- Scaria, Abraham
- Ardinger, Jeffery
|
RU2746991C2 |
ADENO-ASSOCIATED VIRAL VECTOR CONSISTING OF CAPSID PROTEINS PHP_B, NUCLEIC ACID CODING SMN PROTEIN, AND USE THEREOF |
2022 |
- Rodionov Petr Petrovich
- Draj Roman Vasilevich
- Magruk Maksim Andreevich
- Latypov Vitalij Feliksovich
- Saparova Valeriya Byashimovna
|
RU2833225C2 |
PRODUCTION OF AAV IN INSECT CELLS, METHODS AND COMPOSITIONS FOR THIS PURPOSE |
2017 |
|
RU2739596C2 |